应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
APRE Aprea Therapeutics, Inc.
未开盘 07-02 16:00:00 EDT
3.80
-0.23
-5.71%
盘后
3.80
+0.00
0.00%
17:08 EDT
最高
4.02
最低
3.80
成交量
6,217
今开
4.00
昨收
4.03
日振幅
5.46%
总市值
2,063万
流通市值
1,525万
总股本
543.02万
成交额
2.42万
换手率
0.15%
流通股本
401.30万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Aprea Therapeutics Inc-研究第一部分的初步疗效数据可能会在2024年下半年公布
智通财经 · 05-28
Aprea Therapeutics Inc-研究第一部分的初步疗效数据可能会在2024年下半年公布
Aprea Therapeutics Inc——第一阶段剂量升级预计将于2024年第四季度完成Rp2D预计将在2025年第一季度确定
智通财经 · 05-28
Aprea Therapeutics Inc——第一阶段剂量升级预计将于2024年第四季度完成Rp2D预计将在2025年第一季度确定
Aprea Therapeutics, Inc.盘中异动 股价大涨5.34%报5.89美元
自选股智能写手 · 05-14
Aprea Therapeutics, Inc.盘中异动 股价大涨5.34%报5.89美元
Aprea Therapeutics, Inc.盘中异动 早盘股价大跌6.23%报5.16美元
自选股智能写手 · 05-10
Aprea Therapeutics, Inc.盘中异动 早盘股价大跌6.23%报5.16美元
Aprea Therapeutics Inc 预计每股亏损 78 美分 - 财报前瞻
Reuters · 05-10
Aprea Therapeutics Inc 预计每股亏损 78 美分 - 财报前瞻
Aprea Therapeutics, Inc.盘中异动 早盘快速跳水5.37%
自选股智能写手 · 04-11
Aprea Therapeutics, Inc.盘中异动 早盘快速跳水5.37%
Aprea Therapeutics Inc 预计每股亏损 77 美分 - 财报前瞻
Reuters · 03-26
Aprea Therapeutics Inc 预计每股亏损 77 美分 - 财报前瞻
Aprea Therapeutics, Inc.盘中异动 快速下挫6.15%
自选股智能写手 · 03-21
Aprea Therapeutics, Inc.盘中异动 快速下挫6.15%
Aprea Therapeutics, Inc.盘中异动 早盘股价大跌6.46%报5.79美元
自选股智能写手 · 03-18
Aprea Therapeutics, Inc.盘中异动 早盘股价大跌6.46%报5.79美元
Aprea Therapeutics, Inc.盘中异动 急速拉升5.77%报5.87美元
自选股智能写手 · 03-14
Aprea Therapeutics, Inc.盘中异动 急速拉升5.77%报5.87美元
Aprea Therapeutics, Inc.盘中异动 股价大跌5.52%
自选股智能写手 · 03-13
Aprea Therapeutics, Inc.盘中异动 股价大跌5.52%
Aprea Therapeutics, Inc.盘中异动 股价大跌7.14%
自选股智能写手 · 03-05
Aprea Therapeutics, Inc.盘中异动 股价大跌7.14%
Aprea Therapeutics, Inc.盘中异动 临近收盘股价大跌6.97%
自选股智能写手 · 03-02
Aprea Therapeutics, Inc.盘中异动 临近收盘股价大跌6.97%
Aprea Therapeutics, Inc.盘中异动 股价大涨7.78%报7.76美元
自选股智能写手 · 02-29
Aprea Therapeutics, Inc.盘中异动 股价大涨7.78%报7.76美元
Aprea Therapeutics Inc盘中异动 早盘股价大涨6.69%
自选股智能写手 · 02-23
Aprea Therapeutics Inc盘中异动 早盘股价大涨6.69%
加载更多
公司概况
公司名称:
Aprea Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aprea Therapeutics, Inc.于2019年5月根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司,致力于开发和商业化新型癌症疗法,重新激活突变型p53肿瘤抑制蛋白。
发行价格:
--
{"stockData":{"symbol":"APRE","market":"US","secType":"STK","nameCN":"Aprea Therapeutics, Inc.","latestPrice":3.8,"timestamp":1719950400000,"preClose":4.03,"halted":0,"volume":6217,"hourTrading":{"tag":"盘后","latestPrice":3.8,"preClose":3.8,"latestTime":"17:08 EDT","volume":1,"amount":3.8,"timestamp":1719954515272},"delay":0,"floatShares":4012971,"shares":5430215,"eps":-3.301332,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.23,"latestTime":"07-02 16:00:00 EDT","open":4,"high":4.02,"low":3.8,"amount":24161.954583,"amplitude":0.054591,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.301332,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719993600000},"adr":0,"listingDate":1570075200000,"adjPreClose":4.03,"postHourTrading":{"tag":"盘后","latestPrice":3.8,"preClose":3.8,"latestTime":"17:08 EDT","volume":1,"amount":3.8,"timestamp":1719954515272},"volumeRatio":1.1004530750075487,"impliedVol":3.9995,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/APRE","defaultTab":"news","newsList":[{"id":"2438357371","title":"Aprea Therapeutics Inc-研究第一部分的初步疗效数据可能会在2024年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2438357371","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438357371?lang=zh_cn&edition=full","pubTime":"2024-05-28 20:57","pubTimestamp":1716901068,"startTime":"0","endTime":"0","summary":"Aprea Therapeutics Inc-研究第一部分的初步疗效数据可能会在2024年下半年公布","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528205748956ef33b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528205748956ef33b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2438713543","title":"Aprea Therapeutics Inc——第一阶段剂量升级预计将于2024年第四季度完成Rp2D预计将在2025年第一季度确定","url":"https://stock-news.laohu8.com/highlight/detail?id=2438713543","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438713543?lang=zh_cn&edition=full","pubTime":"2024-05-28 20:57","pubTimestamp":1716901060,"startTime":"0","endTime":"0","summary":"Aprea Therapeutics Inc——第一阶段剂量升级预计将于2024年第四季度完成Rp2D预计将在2025年第一季度确定","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282057429ef97850&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282057429ef97850&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2435881548","title":"Aprea Therapeutics, Inc.盘中异动 股价大涨5.34%报5.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435881548","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435881548?lang=zh_cn&edition=full","pubTime":"2024-05-14 23:32","pubTimestamp":1715700722,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日23时32分,Aprea Therapeutics, Inc.股票出现波动,股价快速上涨5.34%。Aprea Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。Aprea Therapeutics, Inc.公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。该信息摘要如下:HC Wainwright & Co.:重申Aprea Therapeutics评级,由买入调整至买入评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142332027a59db9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142332027a59db9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APRE"],"gpt_icon":0},{"id":"2434171851","title":"Aprea Therapeutics, Inc.盘中异动 早盘股价大跌6.23%报5.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434171851","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434171851?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:38","pubTimestamp":1715348281,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时38分,Aprea Therapeutics, Inc.股票出现波动,股价快速下跌6.23%。Aprea Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Aprea Therapeutics, Inc.公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021380187e871bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021380187e871bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APRE","LENZ"],"gpt_icon":0},{"id":"2434300988","title":"Aprea Therapeutics Inc 预计每股亏损 78 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434300988","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434300988?lang=zh_cn&edition=full","pubTime":"2024-05-10 19:59","pubTimestamp":1715342353,"startTime":"0","endTime":"0","summary":" * Aprea Therapeutics Inc 预计在5月13日公布截至2024年3月31日的业绩时,季度收入将没有变化(预计)。* * LSEG 的分析师平均预计 Aprea Therapeutics Inc 每股亏损 78 美分。* 华尔街对 Aprea Therapeutics Inc 的 12 个月目标价中位数为 16.00 美元,高于其上次收盘价 5.50 美元。5月10日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","APRE"],"gpt_icon":0},{"id":"2426682792","title":"Aprea Therapeutics, Inc.盘中异动 早盘快速跳水5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426682792","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426682792?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:01","pubTimestamp":1712844061,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日22时01分,Aprea Therapeutics, Inc.股票出现波动,股价大幅下跌5.37%。Aprea Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.80%。其相关个股中,Rallybio Corporation、Eliem Therapeutics, Inc、Alpine Immune Sciences, Inc.涨幅较大,Scisparc Ltd.、Aptevo Therapeutics Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为402.95%、360.94%、245.49%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Rallybio Corporation、Adial Pharmaceuticals, Inc,振幅分别为46.31%、46.01%、25.32%。Aprea Therapeutics, Inc.公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041122010187681b26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041122010187681b26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APRE","LENZ"],"gpt_icon":0},{"id":"2422698622","title":"Aprea Therapeutics Inc 预计每股亏损 77 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422698622","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422698622?lang=zh_cn&edition=full","pubTime":"2024-03-26 19:01","pubTimestamp":1711450909,"startTime":"0","endTime":"0","summary":" * Aprea Therapeutics Inc 预计将在3月28日公布截至2023年12月31日的业绩(估计),季度收入将有所增长。* 根据LSEG的数据,3位分析师的平均预期显示,这家总部位于宾夕法尼亚州多伊利斯敦的公司预计将实现11万美元的营收。* LSEG 分析师对 Aprea Therapeutics Inc 的平均预期是每股亏损 77 美分。* 华尔街对 Aprea Therapeutics Inc 的 12 个月目标价中位数为 16.00 美元,高于其最新收盘价 6.08 美元。3月26日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","APRE"],"gpt_icon":0},{"id":"2421465800","title":"Aprea Therapeutics, Inc.盘中异动 快速下挫6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421465800","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421465800?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:43","pubTimestamp":1711028631,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时43分,Aprea Therapeutics, Inc.股票出现波动,股价急速跳水6.15%。Aprea Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Aprea Therapeutics, Inc.公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212143517a4e412c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212143517a4e412c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","BK4139"],"gpt_icon":0},{"id":"2420471779","title":"Aprea Therapeutics, Inc.盘中异动 早盘股价大跌6.46%报5.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420471779","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420471779?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:31","pubTimestamp":1710768672,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时31分,Aprea Therapeutics, Inc.股票出现异动,股价快速下跌6.46%。Aprea Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Elicio Therapeutics, Inc.、Galera Therapeutics, Inc.、Xtl生物制药涨幅较大,Zyversa Therapeutics, Inc.、Scisparc Ltd.、Tc Biopharm Plc较为活跃,换手率分别为57.43%、11.43%、6.08%,振幅较大的相关个股有Abeona Therapeutics Inc.、Fresh2 Group Limited、Quince Therapeutics, Inc.,振幅分别为9.50%、8.13%、7.76%。Aprea Therapeutics, Inc.公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213112791b34c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213112791b34c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","BK4139"],"gpt_icon":0},{"id":"2419601020","title":"Aprea Therapeutics, Inc.盘中异动 急速拉升5.77%报5.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419601020","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419601020?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:32","pubTimestamp":1710423122,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时32分,Aprea Therapeutics, Inc.股票出现异动,股价大幅上涨5.77%。Aprea Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.51%。其相关个股中,180 Life Sciences Corp C/Wts 07/11/2025、知临集团、Nuvectis Pharma, Inc.涨幅较大,Novabay Pharmaceuticals, Inc.、知临集团、Gri Bio, Inc.较为活跃,换手率分别为115.98%、61.57%、58.36%,振幅较大的相关个股有知临集团、Renovorx, Inc.、Codexis, Inc.,振幅分别为16.17%、14.40%、8.58%。Aprea Therapeutics, Inc.公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421320387e78f00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421320387e78f00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","BK4139"],"gpt_icon":0},{"id":"2419687603","title":"Aprea Therapeutics, Inc.盘中异动 股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419687603","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419687603?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:57","pubTimestamp":1710338222,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时57分,Aprea Therapeutics, Inc.股票出现异动,股价快速跳水5.52%。Aprea Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Estrella Immunopharma Inc C/Wts 29/09/2028、Nucana Plc、Kintara Therapeutics, Inc.涨幅较大,Kintara Therapeutics, Inc.、Nucana Plc、Revelation Biosciences, Inc.较为活跃,换手率分别为173.75%、55.01%、31.97%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Nucana Plc、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为82.54%、44.25%、32.67%。Aprea Therapeutics, Inc.公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132157027a4c5556&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132157027a4c5556&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APRE"],"gpt_icon":0},{"id":"2417171144","title":"Aprea Therapeutics, Inc.盘中异动 股价大跌7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417171144","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417171144?lang=zh_cn&edition=full","pubTime":"2024-03-05 23:00","pubTimestamp":1709650817,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日23时00分,Aprea Therapeutics, Inc.股票出现异动,股价快速跳水7.14%。Aprea Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.27%。Aprea Therapeutics, Inc.公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030523001879178322&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030523001879178322&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APRE"],"gpt_icon":0},{"id":"2416674838","title":"Aprea Therapeutics, Inc.盘中异动 临近收盘股价大跌6.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416674838","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416674838?lang=zh_cn&edition=full","pubTime":"2024-03-02 04:52","pubTimestamp":1709326322,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日04时52分,Aprea Therapeutics, Inc.股票出现异动,股价急速跳水6.97%。Aprea Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.63%。其相关个股中,Cardiff Oncology, Inc.、Adial Pharmaceuticals, Inc、Biovie Inc.涨幅较大,Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Enveric Biosciences, Inc.较为活跃,换手率分别为4630.32%、551.22%、486.60%,振幅较大的相关个股有Biovie Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Carmell Corp C/Wts 12/07/2028 ,振幅分别为125.00%、120.70%、87.50%。Aprea Therapeutics, Inc.公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403020452037a48a4dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403020452037a48a4dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","BK4139"],"gpt_icon":0},{"id":"2416240075","title":"Aprea Therapeutics, Inc.盘中异动 股价大涨7.78%报7.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416240075","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416240075?lang=zh_cn&edition=full","pubTime":"2024-02-29 23:23","pubTimestamp":1709220203,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日23时23分,Aprea Therapeutics, Inc.股票出现波动,股价快速拉升7.78%。截至发稿,该股报7.76美元/股,成交量1827股,换手率0.05%,振幅5.69%。Aprea Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.47%。Aprea Therapeutics, Inc.公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022923232487e74ec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022923232487e74ec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","BK4139"],"gpt_icon":0},{"id":"2413476258","title":"Aprea Therapeutics Inc盘中异动 早盘股价大涨6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413476258","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413476258?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:40","pubTimestamp":1708699223,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时40分,Aprea Therapeutics Inc股票出现波动,股价急速拉升6.69%。截至发稿,该股报6.80美元/股,成交量1383股,换手率0.04%,振幅0.16%。Aprea Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.65%。Aprea Therapeutics Inc公司简介:Aprea Therapeutics Inc是一家临床生物制药公司,致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402232240237a4624cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402232240237a4624cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","BK4139","OCEA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aprea.com","stockEarnings":[{"period":"1week","weight":-0.0843},{"period":"1month","weight":-0.2034},{"period":"3month","weight":-0.4303},{"period":"6month","weight":-0.246},{"period":"1year","weight":0.1736},{"period":"ytd","weight":-0.1915}],"compareEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.041},{"period":"3month","weight":0.057},{"period":"6month","weight":0.1749},{"period":"1year","weight":0.2371},{"period":"ytd","weight":0.1551}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aprea Therapeutics, Inc.于2019年5月根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司,致力于开发和商业化新型癌症疗法,重新激活突变型p53肿瘤抑制蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.060151},{"month":2,"riseRate":0.4,"avgChangeRate":-0.006523},{"month":3,"riseRate":0.4,"avgChangeRate":-0.083115},{"month":4,"riseRate":0,"avgChangeRate":-0.145108},{"month":5,"riseRate":0,"avgChangeRate":-0.155075},{"month":6,"riseRate":0.4,"avgChangeRate":0.033427},{"month":7,"riseRate":0.2,"avgChangeRate":-0.045617},{"month":8,"riseRate":0.5,"avgChangeRate":0.025226},{"month":9,"riseRate":0.5,"avgChangeRate":-0.015374},{"month":10,"riseRate":0.25,"avgChangeRate":-0.071945},{"month":11,"riseRate":0.6,"avgChangeRate":-0.056219},{"month":12,"riseRate":0.4,"avgChangeRate":-0.03668}],"exchange":"NASDAQ","name":"Aprea Therapeutics, Inc.","nameEN":"Aprea Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aprea Therapeutics, Inc.(APRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aprea Therapeutics, Inc.(APRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aprea Therapeutics, Inc.,APRE,Aprea Therapeutics, Inc.股票,Aprea Therapeutics, Inc.股票老虎,Aprea Therapeutics, Inc.股票老虎国际,Aprea Therapeutics, Inc.行情,Aprea Therapeutics, Inc.股票行情,Aprea Therapeutics, Inc.股价,Aprea Therapeutics, Inc.股市,Aprea Therapeutics, Inc.股票价格,Aprea Therapeutics, Inc.股票交易,Aprea Therapeutics, Inc.股票购买,Aprea Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aprea Therapeutics, Inc.(APRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aprea Therapeutics, Inc.(APRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}